## MELI: MercadoLibre, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 1.04 indicates fundamental undervaluation. Quality metrics strong (ROE 41%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($1910.21)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | BTIG | $2750 | $2750 | 0% |
| 2025-11-24 | UBS | $2900 | $3000 | -3% |
| 2025-11-14 | BTIG | $2750 | $2750 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | BTIG | reit | Buy |
| 2025-11-24 | UBS | main | Buy |
| 2025-11-14 | BTIG | reit | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 7.0% (+78.3%)
- BAILLIE GIFFORD & CO: 6.5% (-5.4%)
- Morgan Stanley: 3.9% (+0.3%)
- Capital Research Glo: 3.6% (+3.4%)
- Capital World Invest: 3.4% (+1.3%)

### Key Risks

1. Long-term trend broken: trading 9.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.04 suggests fair value with growth premium. Forward P/E 33.7x attractive for 51% earnings growth. Quality metrics strong (ROE 41%). Balance sheet: $2.5B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $99.9B |
| Beta | 1.43 |
| 52W Range | $1646.00 - $2645.22 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.04 |
| Forward P/E | 33.7 |
| Current P/E | 51.0 |
| YoY Growth | 51.2% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -5.1% to -2.2% (+2.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 6.2pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.3%) - potential reversal signal. Below SMA200 (0.91x), long-term trend not supportive. MACD histogram positive (5.60), confirming momentum. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.24% (CS: 25) | Weak |
| RSI_14 | 46.3 | Neutral |
| MACD Histogram | 5.60 | Bullish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 0.945x | Below |
| vs SMA200 | 0.908x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $2064.55
- **Stop Loss:** $1910.21 (7.5% risk)
- **Target:** $2373.23 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 6
- **Position Value:** $12,387.30
- **Portfolio %:** 12.39%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-02-24 (Est: $11.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.30 | $8.32 | -10.5% |
| 2025Q2 | $11.89 | $10.31 | -13.3% |
| 2025Q1 | $8.27 | $9.74 | +17.8% |
| 2024Q4 | $7.56 | $12.61 | +66.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*